A procurement only guide for documenting exact CTO guidewire references and avoiding unsafe assumptions about clinical attributes. The purpose is to help teams make a clearer, better documented decision without turning a commercial checklist into a clinical recommendation.
Quick answer
CTO wire families may include highly specialised variants whose commercial names do not fully communicate tip, coating and support characteristics. A stronger approach produces an exact reference enquiry that leaves clinical selection with the authorised team.
This cluster article supports the broader guide on Interventional Cardiology Devices: A Procurement Guide. The main search topic for this guide is CTO guidewire RFQ. Related language includes chronic total occlusion guidewire, CTO wire procurement, interventional guidewire sourcing, but the article uses those terms only where they help the reader rather than repeating them mechanically.
Why this matters
Interventional cardiology purchasing is reference sensitive. A product family can contain many sizes, lengths, curves, coatings and delivery configurations. Procurement should verify the approved requirement, not infer clinical suitability from a catalogue description.
For cath lab buyers and interventional cardiology procurement teams, the practical risk is not limited to price. A wrong reference, incomplete pack, uncertain shelf life, late shipment or unsupported alternative can create rework, unused inventory and avoidable delays. A useful buying process therefore connects the technical request, commercial offer and receiving standard.
The best time to resolve ambiguity is before the purchase order. Once goods are dispatched, every unclear field becomes harder and more expensive to correct. The controls below are designed to move important questions to the beginning of the process.
Key checks
| Check | What to do | Why it matters |
|---|---|---|
| Clinician approved reference | Start with the exact approved product and variant. | Procurement should not select a CTO wire from marketing descriptions. |
| Dimensions | Record diameter and length exactly. | These are necessary but not sufficient identifiers. |
| Variant characteristics | Copy the approved manufacturer variant description without simplifying it. | Small wording differences may indicate a different product. |
| Packaging and expiry | Confirm sterile pack, quantity and remaining shelf life. | Specialised items may have low usage and higher expiry risk. |
| Alternative control | Require proposed alternatives to be separated and fully documented. | A commercial substitute is not a clinical equivalent. |
These checks should be adapted to product risk and organisational policy. A routine low risk item and a sterile implantable or procedure critical device should not automatically receive the same depth of review.
A practical workflow
- Step 1: Receive a signed or controlled clinical request. Record the owner, evidence and completion date so the action can be checked later.
- Step 2: Verify the reference against current manufacturer material. Record the owner, evidence and completion date so the action can be checked later.
- Step 3: Send a reference specific RFQ. Record the owner, evidence and completion date so the action can be checked later.
- Step 4: Ask the vendor to state source, expiry and availability. Record the owner, evidence and completion date so the action can be checked later.
- Step 5: Route any deviation to the clinical approver. Record the owner, evidence and completion date so the action can be checked later.
- Step 6: Check the exact reference and lot at receiving. Record the owner, evidence and completion date so the action can be checked later.
A workflow is only useful when exceptions are visible. If a field is unknown, mark it as unknown and assign an owner. Do not fill the gap with an assumption merely to complete the form. The decision record should show what was confirmed, what remained conditional and which stakeholder accepted the residual risk.
Documentation and verification
Current manufacturer labelling and instructions are the primary product specific sources. Procurement teams can confirm identity, pack, expiry and compatibility statements, while clinical selection and use remain the responsibility of qualified healthcare professionals.
Every RFQ line should be traceable to an exact approved variant. Proposed alternatives need their own line, supporting documents and named clinical approval. This separation protects both the buyer and the supplier from accidental substitution.
For every important document, record the document title, issuing organisation, product or company scope, version or validity date, source and date reviewed. This simple index helps prevent a valid document from being attached to the wrong product or reused after it becomes outdated.
Minimum decision record
- The original request and clinician or technical approval where required
- The exact quoted product identity, pack and quantity
- Supplier assumptions, deviations and proposed alternatives
- Quality, regulatory and traceability evidence proportionate to risk
- Price basis, landed cost assumptions, lead time and shelf life
- Approval names, dates and any conditions
- Receiving checks and final disposition of discrepancies
Questions to ask before approval
- Can the supplier demonstrate the clinician approved reference described in the RFQ, and can the answer be connected to the exact quoted product?
- Can the supplier demonstrate the dimensions described in the RFQ, and can the answer be connected to the exact quoted product?
- Can the supplier demonstrate the variant characteristics described in the RFQ, and can the answer be connected to the exact quoted product?
- Can the supplier demonstrate the packaging and expiry described in the RFQ, and can the answer be connected to the exact quoted product?
- Can the supplier demonstrate the alternative control described in the RFQ, and can the answer be connected to the exact quoted product?
Ask suppliers to answer against each RFQ line rather than in a general email. A line level response makes it easier to compare offers, detect partial matches and transfer the approved information into the purchase order.
Common mistakes
- Choosing a CTO wire by a generic hard or soft label. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
- Accepting a similar family name as an exact match. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
- Ordering excess slow moving stock without expiry analysis. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
- Allowing urgency to bypass reference verification. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
Most procurement errors are not caused by one dramatic failure. They develop through several small gaps, such as an abbreviated name, an unrecorded assumption and a receiving check that compares quantity but not reference. Closing those gaps consistently is more effective than adding a large document request after a problem occurs.
Practical example
An urgent enquiry receives an offer for a similarly named wire with a different suffix. The buyer marks it as an alternative, obtains the current product document and sends it to the authorised clinician instead of treating the suffix as a minor difference.
The lesson is not that every enquiry must become slow. A structured template is usually faster because it reduces repeated emails and makes approval requirements visible from the start.
Final checklist
- Clinician approved reference has been reviewed: Start with the exact approved product and variant.
- Dimensions has been reviewed: Record diameter and length exactly.
- Variant characteristics has been reviewed: Copy the approved manufacturer variant description without simplifying it.
- Packaging and expiry has been reviewed: Confirm sterile pack, quantity and remaining shelf life.
- Alternative control has been reviewed: Require proposed alternatives to be separated and fully documented.
Before closing the file, confirm that the purchase order reflects the approved quotation rather than an earlier draft. At receiving, compare the physical label and condition with the same approved record. This completes the link between request, order and delivered product.
Frequently asked questions
Can this article be used to select a CTO guidewire?
No. It is strictly a procurement and documentation guide. Selection and use require qualified clinical judgment.
Why are suffixes and variant names important?
They may distinguish product characteristics within a family. Always verify the exact manufacturer reference.
How can urgent sourcing remain controlled?
Use a predefined escalation process, exact reference checks and documented clinical approval for any deviation.
Related AJA guides
Browse the medical device product catalogue, review the brand sourcing profiles or read about AJA International’s quality and compliance approach.
Send the manufacturer, catalogue number, configuration, quantity, destination and required delivery date. AJA International can review the enquiry and identify any missing information before quoting.
Official resources and further reading
- FDA medical device information
- European Commission medical devices sector
- MedTech Europe medical technology overview
Editorial review: Prepared for publication in 2026. Regulatory, registration and product information can change, so readers should confirm current requirements and manufacturer documentation before acting.